{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-067978","form_type":"8-K","ticker":"VIR","cik":"0001706431","company_name":"Vir Biotechnology, Inc.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.216179+00:00","generated_at":"2026-06-18T04:35:37.118439+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vir Biotechnology discloses $220M exposure to Silicon Valley Bank after FDIC seizure","bullets":["FDIC took control of Silicon Valley Bank (SVB) on March 10, 2023.","Vir holds approximately $220 million in operating accounts at SVB as of March 10.","Total cash, cash equivalents and investments were $2.4 billion as of December 31, 2022.","Company is monitoring the situation but has not disclosed any impact on operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-067978","json":"https://secwatch.observer/filing/0001193125-23-067978.json","markdown":"https://secwatch.observer/filing/0001193125-23-067978.md","text":"https://secwatch.observer/filing/0001193125-23-067978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1706431/000119312523067978/0001193125-23-067978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1706431/000119312523067978/d409774d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:35:37.118439+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}